<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1327" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1327/" /><meta name="ncbi_pagename" content="X-Linked Opitz G/BBB Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>X-Linked Opitz G/BBB Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="X-Linked Opitz G/BBB Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/04/05" /><meta name="citation_author" content="Germana Meroni" /><meta name="citation_pmid" content="20301502" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1327/" /><meta name="citation_keywords" content="Opitz Syndrome, X-Linked" /><meta name="citation_keywords" content="XLOS" /><meta name="citation_keywords" content="Opitz Syndrome, X-Linked" /><meta name="citation_keywords" content="XLOS" /><meta name="citation_keywords" content="E3 ubiquitin-protein ligase Midline-1" /><meta name="citation_keywords" content="MID1" /><meta name="citation_keywords" content="X-Linked Opitz G/BBB Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="X-Linked Opitz G/BBB Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Germana Meroni" /><meta name="DC.Date" content="2018/04/05" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1327/" /><meta name="description" content="X-linked Opitz G/BBB syndrome (X-OS) is a multiple-congenital-anomaly disorder characterized by facial anomalies (hypertelorism, prominent forehead, widow's peak, broad nasal bridge, anteverted nares), genitourinary abnormalities (hypospadias, cryptorchidism, and hypoplastic/bifid scrotum), and laryngotracheoesophageal defects. Developmental delay and intellectual disability are observed in about 50% of affected males. Cleft lip and/or palate are present in approximately 50% of affected individuals. Other malformations (present in &lt;50% of individuals) include congenital heart defects, imperforate or ectopic anus, and midline brain defects (Dandy-Walker malformation and agenesis or hypoplasia of the corpus callosum and/or cerebellar vermis). Wide clinical variability occurs even among members of the same family. Female heterozygotes usually manifest hypertelorism only." /><meta name="og:title" content="X-Linked Opitz G/BBB Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="X-linked Opitz G/BBB syndrome (X-OS) is a multiple-congenital-anomaly disorder characterized by facial anomalies (hypertelorism, prominent forehead, widow's peak, broad nasal bridge, anteverted nares), genitourinary abnormalities (hypospadias, cryptorchidism, and hypoplastic/bifid scrotum), and laryngotracheoesophageal defects. Developmental delay and intellectual disability are observed in about 50% of affected males. Cleft lip and/or palate are present in approximately 50% of affected individuals. Other malformations (present in &lt;50% of individuals) include congenital heart defects, imperforate or ectopic anus, and midline brain defects (Dandy-Walker malformation and agenesis or hypoplasia of the corpus callosum and/or cerebellar vermis). Wide clinical variability occurs even among members of the same family. Female heterozygotes usually manifest hypertelorism only." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1327/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/opitz/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1327/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88C08DE03FA1510000000008F7033F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1327_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1327_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mtm/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/opd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1327_"><span class="title" itemprop="name">X-Linked Opitz G/BBB Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Opitz Syndrome, X-Linked; XLOS</div><p class="contrib-group"><span itemprop="author">Germana Meroni</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1327_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1327_ai__"><div class="contrib half_rhythm"><span itemprop="author">Germana Meroni</span>, PhD<div class="affiliation small">Department of Life Sciences<br />University of Trieste<br />Trieste, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.stinu@inoremg" class="oemail">ti.stinu@inoremg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">December 17, 2004</span>; Last Update: <span itemprop="dateModified">April 5, 2018</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="opitz.Summary" itemprop="description"><h2 id="_opitz_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS) is a multiple-<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>-anomaly disorder characterized by facial anomalies (hypertelorism, prominent forehead, widow's peak, broad nasal bridge, anteverted nares), genitourinary abnormalities (hypospadias, cryptorchidism, and hypoplastic/bifid scrotum), and laryngotracheoesophageal defects. Developmental delay and intellectual disability are observed in about 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. Cleft lip and/or palate are present in approximately 50% of affected individuals. Other malformations (present in &#x0003c;50% of individuals) include congenital heart defects, imperforate or ectopic anus, and midline brain defects (Dandy-Walker malformation and agenesis or hypoplasia of the corpus callosum and/or cerebellar vermis). Wide clinical variability occurs even among members of the same family. Female heterozygotes usually manifest hypertelorism only.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of X-OS is established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> most often by clinical findings. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MID1</i> in a male proband by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> establishes the diagnosis if clinical features are inconclusive. The diagnosis of X-OS can be established in a female with suggestive clinical features by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variant in <i>MID1</i> on molecular genetic testing.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Management of anomalies by a multidisciplinary team; surgical treatment of medically significant laryngotracheoesophageal malformations; tracheostomy as needed; standard surgical management of hypospadias, cleft lip/palate, imperforate anus, heart defects; speech therapy; neuropsychological and educational support.</p><p><i>Prevention of secondary complications</i>: Antireflux measurements to minimize risk of aspiration.</p><p><i>Surveillance</i>: Based on the type of malformations present; regular monitoring of hearing for those with cleft lip/palate.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>X-OS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a>. If the mother of an affected male is a carrier, the chance of transmitting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy is 50%. Sons who inherit the pathogenic variant will be affected; daughters who inherit the pathogenic variant will be carriers and will usually manifest hypertelorism. Mildly affected males who have children will pass the pathogenic variant to all of their daughters and none of their sons. Prenatal testing is possible for pregnancies at risk if the pathogenic variant in the family has been identified.</p></div></div><div id="opitz.Diagnosis"><h2 id="_opitz_Diagnosis_">Diagnosis</h2><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS) is diagnosed most often on the basis of clinical findings. There is <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, even within the same family. The manifestations of X-OS are classified into major and minor findings based on frequency of occurrence. Formal diagnostic criteria for X-OS have not been established.</p><div id="opitz.Suggestive_Findings"><h3>Suggestive Findings</h3><p>The clinical diagnosis of X-OS <b>should be suspected</b> in a male with the following major and/or minor findings.</p><p><b>Major (more frequent) findings</b></p><ul><li class="half_rhythm"><div>Hypertelorism and/or telecanthus (present in virtually all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals)</div></li><li class="half_rhythm"><div>All degrees of hypospadias that, in the most severe form, can be associated with renal malformations (85%-90%)</div></li><li class="half_rhythm"><div>Laryngotracheoesophageal abnormalities, primarily laryngeal cleft, resulting in swallowing difficulties and respiratory dysfunction (60%-70%)</div></li><li class="half_rhythm"><div>A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance &#x02013; although <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, even within the same family, should be taken into consideration</div></li></ul><p><b>Minor findings</b> (found in &#x02264;50% of individuals)</p><ul><li class="half_rhythm"><div>Intellectual disability and developmental delay</div></li><li class="half_rhythm"><div>Cleft lip and/or palate</div></li><li class="half_rhythm"><div>Congenital heart defects (e.g., ventricular septal defect, atrial septal defect, persistent left superior vena cava, patent ductus arteriosus)</div></li><li class="half_rhythm"><div>Imperforate or ectopic anus</div></li><li class="half_rhythm"><div>Midline defects of the brain including agenesis of the corpus callosum and cerebellar vermis agenesis or hypoplasia</div></li></ul></div><div id="opitz.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS) <b>is established</b> in a male proband with the <a href="#opitz.Suggestive_Findings">above clinical findings</a>. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MID1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis if clinical features are inconclusive (see <a class="figpopup" href="/books/NBK1327/table/opitz.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figopitzTmoleculargenetictestingusedi" rid-ob="figobopitzTmoleculargenetictestingusedi">Table 1</a>).</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of X-OS <b>is established</b> in a female proband with suggestive clinical features and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MID1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1327/table/opitz.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figopitzTmoleculargenetictestingusedi" rid-ob="figobopitzTmoleculargenetictestingusedi">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of X-OS is broad, individuals with the distinctive findings described in <a href="#opitz.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#opitz.Option_1">Option 1</a>), whereas those in whom the diagnosis of X-OS has not been considered are more likely to be diagnosed using genomic testing (see <a href="#opitz.Option_2">Option 2</a>).</p><div id="opitz.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of X-OS, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>MID1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>MID1</i> and other genes of interest (see <a href="#opitz.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1327/table/opitz.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figopitzTmoleculargenetictestingusedi" rid-ob="figobopitzTmoleculargenetictestingusedi">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="opitz.Option_2"><h4>Option 2</h4><p>When the diagnosis of X-OS is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="opitz.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in X-Linked Opitz G/BBB Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1327/table/opitz.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opitz.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MID1</i></td><td headers="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~25%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_opitz.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10 individuals&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="opitz.TF.1.1"><p class="no_margin">See <a href="/books/NBK1327/#opitz.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="opitz.TF.1.2"><p class="no_margin">See <a href="#opitz.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="opitz.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="opitz.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="opitz.TF.1.5"><p class="no_margin">The detection of an <i>MID1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an individual without a family history of X-OS is approximately 15%. The pathogenic variant detection rate in individuals with documented <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance is &#x0003e;50%. [<a class="bk_pop" href="#opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</a>, <a class="bk_pop" href="#opitz.REF.cox.2000.2553">Cox et al 2000</a>, <a class="bk_pop" href="#opitz.REF.de_falco.2003.222">De Falco et al 2003</a>, <a class="bk_pop" href="#opitz.REF.winter.2003.249">Winter et al 2003</a>, <a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>, <a class="bk_pop" href="#opitz.REF.so.2005.1">So et al 2005</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>].</p></div></dd><dt>6. </dt><dd><div id="opitz.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="opitz.TF.1.7"><p class="no_margin">Three whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions have been reported [<a class="bk_pop" href="#opitz.REF.winter.2003.249">Winter et al 2003</a>, <a class="bk_pop" href="#opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>]. In addition, single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions and duplications have been reported [<a class="bk_pop" href="#opitz.REF.winter.2003.249">Winter et al 2003</a>, <a class="bk_pop" href="#opitz.REF.h_ning.2013.188">H&#x000fc;ning et al 2013</a>, <a class="bk_pop" href="#opitz.REF.migliore.2013.404">Migliore et al 2013</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="opitz.Clinical_Characteristics"><h2 id="_opitz_Clinical_Characteristics_">Clinical Characteristics</h2><div id="opitz.Clinical_Description"><h3>Clinical Description</h3><p><b>Affected males.</b> <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS) is characterized by clinical abnormalities of primarily midline structures. These defects include facial anomalies, genitourinary abnormalities, laryngotracheoesophageal defects, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects. Developmental delay and intellectual disability are common. Wide clinical variability has been described; individuals with an <i>MID1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may manifest only some of the clinical features with different degrees of severity, even among members of the same family.</p><div id="opitz.T.incidence_of_clinical_features_i" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Incidence of Clinical Features in Males with X-OS with an Identified <i>MID1</i> Pathogenic Variant</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1327/table/opitz.T.incidence_of_clinical_features_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opitz.T.incidence_of_clinical_features_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Feature</th><th id="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"># of Males with Clinical Feature /<br />Total # of Males</th></tr></thead><tbody><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypertelorism</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">82/82</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypospadias</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">65/85</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laryngotracheoesophageal defects</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">46/85</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Intellectual disability and/or developmental delay</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28/85</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cleft lip//palate</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">42/85</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital heart defects</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20/85</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anal defects</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/85</td></tr><tr><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Brain abnormalities</td><td headers="hd_h_opitz.T.incidence_of_clinical_features_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18/35&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al [2008]</a>, <a class="bk_pop" href="#opitz.REF.li.2015.95">Li et al [2015]</a></p></div></dd><dt>1. </dt><dd><div id="opitz.TF.2.1"><p class="no_margin">Includes males with X-OS who have undergone MRI examination</p></div></dd></dl></div></div></div><p><b>Facial appearance and head anomalies.</b> The facial appearance of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males is characterized by hypertelorism, which can also be accompanied by telecanthus, a prominent forehead, widow's peak, broad nasal bridge, anteverted nares, low-set and malformed ears, microcephaly, large fontanelle, and/or prominent metopic suture. Unilateral or bilateral cleft lip and/or palate is present in approximately 50% of affected individuals. Other oral manifestations include high-arched palate, ankyloglossia, micrognathia, hypodontia, and neonatal teeth [<a class="bk_pop" href="#opitz.REF.robin.1996.305">Robin et al 1996</a>, <a class="bk_pop" href="#opitz.REF.shaw.2006.185">Shaw et al 2006</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>].</p><p><b>Urogenital abnormalities.</b> Hypospadias of varying severity is present in approximately 90% of males with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome and is often associated with other genital anomalies such as cryptorchidism and hypoplastic/bifid scrotum. Severe hypospadias can be associated with urinary tract dysfunction (e.g., vesicoureteral reflux, hydronephrosis) [<a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>, <a class="bk_pop" href="#opitz.REF.zhang.2011.348">Zhang et al 2011</a>].</p><p><b>Laryngotracheoesophageal (LTE) defects.</b> LTE abnormalities may result in coughing and choking with feeding, recurrent pneumonia, and life-threatening aspiration. In their most severe form, LTE defects are manifest as laryngeal and tracheoesophageal clefts and in more mild form as tracheoesophageal fistulae or LTE dysmotility. The incidence of respiratory and/or gastroesophageal symptoms is probably underestimated because mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may only manifest functional swallowing difficulties that improve with age and eventually disappear during infancy [<a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>].</p><p><b>Neurologic findings.</b> More than one third of individuals with X-OS show developmental delay and intellectual disability; they frequently manifest delay in onset of walking, short attention span, learning difficulties, and speech problems. In some cases, these delays are secondary to surgical interventions. Midline brain anatomic defects including agenesis or hypoplasia of the corpus callosum and/or cerebellar vermis and Dandy-Walker malformations were identified in 50% of individuals with an <i>MID1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who underwent MRI examination [<a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>].</p><p><b>Congenital heart disease.</b> Approximately 20% of individuals with X-OS present with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart anomalies (e.g., ventricular septal defect, atrial septal defect, coarctation of the aorta, persistent left superior vena cava, patent ductus arteriosus, patent foramen ovale) [<a class="bk_pop" href="#opitz.REF.robin.1996.305">Robin et al 1996</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>].</p><p><b>Anal abnormalities</b> are present in approximately 20% of individuals with X-OS (e.g., imperforate anus, ectopic anus) [<a class="bk_pop" href="#opitz.REF.robin.1996.305">Robin et al 1996</a>, <a class="bk_pop" href="#opitz.REF.de_falco.2003.222">De Falco et al 2003</a>, <a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>].</p><p><b>Ophthalmologic features.</b> Refractive error and strabismus have been reported.</p><p><b>Heterozygous females</b> usually have hypertelorism only, and rarely other manifestations (e.g., characteristic facial features [anteverted nares, short nose, short uvula, high arched palate, micrognathia], tracheoesophageal cleft or esophageal stenosis, anal malformations) [<a class="bk_pop" href="#opitz.REF.so.2005.1">So et al 2005</a>].</p></div><div id="opitz.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>In general, no <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed. Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and frameshift variants, insertions, and deletions all result in highly variable phenotypes even within the same family [<a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>].</p><p>Two possible exceptions are:</p><ul><li class="half_rhythm"><div>An association between truncating variants and the presence of anatomic brain abnormalities, in particular cerebellar defects [<a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>];</div></li><li class="half_rhythm"><div>Possible correlation of a mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with pathogenic variants in the fibronectin type III <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein [<a class="bk_pop" href="#opitz.REF.mnayer.2006.198">Mnayer et al 2006</a>].</div></li></ul></div><div id="opitz.Penetrance"><h3>Penetrance</h3><p>Usually the presence of an <i>MID1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is associated with clinical findings of X-OS; however, recently an instance of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> has been reported [<a class="bk_pop" href="#opitz.REF.ruiter.2010.195">Ruiter et al 2010</a>].</p></div><div id="opitz.Nomenclature"><h3>Nomenclature</h3><p>Opitz G/BBB syndrome was first reported as two separate entities, BBB syndrome [<a class="bk_pop" href="#opitz.REF.opitz.b">Opitz et al 1969b</a>] and G syndrome [<a class="bk_pop" href="#opitz.REF.opitz.a">Opitz et al 1969a</a>]. Subsequently, it has become apparent that the two syndromes identified in 1969 are in fact a single entity, now named Opitz G/BBB syndrome.</p><p>Other names, no longer used, include hypospadias-dysphagia syndrome, Opitz-Frias syndrome, telecanthus with associated abnormalities, and hypertelorism-hypospadias syndrome.</p><p>Of note, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS; OSX; type I) is distinct from <a href="/books/n/gene/gr_22q11deletion/">autosomal dominant Opitz G/BBB syndrome</a> (ADOS; type II).</p></div><div id="opitz.Prevalence"><h3>Prevalence</h3><p>The prevalence of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome ranges from 1:50,000 to 1:100,000 males.</p></div></div><div id="opitz.Genetically_Related_Allelic_Disord"><h2 id="_opitz_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No other <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is known to be associated with pathogenic variants in <i>MID1</i>.</p></div><div id="opitz.Differential_Diagnosis"><h2 id="_opitz_Differential_Diagnosis_">Differential Diagnosis</h2><div id="opitz.T.disorders_to_consider_in_the_dif" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of X-OS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1327/table/opitz.T.disorders_to_consider_in_the_dif/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opitz.T.disorders_to_consider_in_the_dif_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s) / Genetic Mechanism</th><th id="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4" id="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping with X-OS</th><th headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4" id="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from X-OS</th></tr></thead><tbody><tr><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gr_22q11deletion/">AD Opitz G/BBB syndrome</a> (ADOS; Opitz G/BBB syndrome, type II)</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPECC1L</i><br />22q11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>1</sup></td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypertelorism</div></li><li class="half_rhythm"><div>Swallowing difficulties</div></li><li class="half_rhythm"><div>Hypospadias</div></li><li class="half_rhythm"><div>DD</div></li></ul>
</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MOI</div></li><li class="half_rhythm"><div>More complex <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in females w/ADOS</div></li></ul>
</td></tr><tr><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">FG syndrome&#x000a0;<sup>2</sup></td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MED12</i><br /><i>FLNA</i><br /><i>CASK</i></td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial dysmorphism</div></li><li class="half_rhythm"><div>Congenital heart defects</div></li><li class="half_rhythm"><div>Hypospadias</div></li><li class="half_rhythm"><div>DD/ID</div></li></ul>
</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Congenital hypotonia w/joint hyperlaxity evolving into spasticity</div></li><li class="half_rhythm"><div>Chronic constipation</div></li><li class="half_rhythm"><div>Characteristic personality</div></li></ul>
</td></tr><tr><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniofrontonasal dysplasia (OMIM <a href="https://omim.org/entry/304110" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">304110</a>)</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EFNB1</i></td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial dysmorphism</div></li><li class="half_rhythm"><div>Cleft lip/palate</div></li><li class="half_rhythm"><div>Hypospadias</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Hypoplasia or agenesis of corpus callosum</div></li></ul>
</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Skeletal, skin, nail, &#x00026; hair defects</div></li><li class="half_rhythm"><div>Chest defects</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Hypotonia</div></li></ul>
</td></tr><tr><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mws/">Mowat-Wilson syndrome</a></td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ZEB2</i></td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial dysmorphism</div></li><li class="half_rhythm"><div>Cardiovascular defects</div></li><li class="half_rhythm"><div>Hypospadias</div></li><li class="half_rhythm"><div>DD</div></li><li class="half_rhythm"><div>Hypoplasia or agenesis of corpus callosum</div></li></ul>
</td><td headers="hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_1_4 hd_h_opitz.T.disorders_to_consider_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ocular and gastrointestinal abnormalities</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Microcephaly</div></li><li class="half_rhythm"><div>Pectus excavatum</div></li><li class="half_rhythm"><div>Hypotonia</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt></dt><dd><div><p class="no_margin">DD = developmental delay</p></div></dd><dt></dt><dd><div><p class="no_margin">ID = intellectual disability</p></div></dd><dt>1. </dt><dd><div id="opitz.TF.3.1"><p class="no_margin">AD Opitz G/BBB syndrome can be caused either by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPECC1L</i> [OMIM <a href="https://omim.org/entry/145410" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">145410</a>] or by <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> region 22q11.2.</p></div></dd><dt>2. </dt><dd><div id="opitz.TF.3.2"><p class="no_margin">FG syndrome is genetically heterogeneous and includes several <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> forms: FGS1, caused by pathogenic variants in <i>MED12</i> (see <a href="/books/n/gene/fg/"><i>MED12</i>-Related Disorders</a>); FGS2 (OMIM <a href="https://omim.org/entry/300321" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300321</a>), associated with pathogenic variants in <i>FLNA</i> (<a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> Xq28); FGS3 (linked to Xp22.3) (OMIM <a href="https://omim.org/entry/300406" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300406</a>); FGS4 (OMIM <a href="https://omim.org/entry/300422" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300422</a>), caused by pathogenic variants in <i>CASK</i> (locus Xp11.4); FGS5 (linked to Xq22.3) (OMIM <a href="https://omim.org/entry/300581" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300581</a>).</p></div></dd></dl></div></div></div></div><div id="opitz.Management"><h2 id="_opitz_Management_">Management</h2><div id="opitz.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome, the following evaluations by a multidisciplinary team (including craniofacial surgeon, ophthalmologist, pediatrician, pediatric urologist, cardiologist, pulmonologist, speech pathologist, and clinical geneticist) are recommended if they have not already been performed:</p><ul><li class="half_rhythm"><div>Past medical history and physical examination with attention to palate, heart, genitourinary system, and lower respiratory system</div></li><li class="half_rhythm"><div>Assessment of hypospadias by a urologist, including ultrasound examination to evaluate for renal/urinary tract abnormalities in males with severe hypospadias</div></li><li class="half_rhythm"><div>Laryngoscopy and chest x-ray in individuals who have choking with feeding, recurrent pneumonia, and/or aspiration</div></li><li class="half_rhythm"><div>Developmental evaluation</div></li><li class="half_rhythm"><div>Referral of individuals with cleft lip/palate to a craniofacial surgeon</div></li><li class="half_rhythm"><div>Echocardiogram</div></li><li class="half_rhythm"><div>Assessment of anal position and patency</div></li><li class="half_rhythm"><div>Complete ophthalmology evaluation including assessment of visual acuity, refractive error, and ocular alignment for possible strabismus</div></li></ul></div><div id="opitz.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of anomalies by a multidisciplinary team (including craniofacial surgeon, ophthalmologist, pediatrician, pediatric urologist, cardiologist, pulmonologist, speech pathologist, and clinical geneticist) to help assure coordination of care is indicated.</p><ul><li class="half_rhythm"><div>Surgical intervention as needed for hypospadias</div></li><li class="half_rhythm"><div>Surgical treatment of medically significant laryngotracheoesophageal (LTE) abnormalities. Often tracheostomy is necessary initially to assure an adequate airway.</div></li><li class="half_rhythm"><div>Neuropsychological support. Many males with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome require special educational programs.</div></li><li class="half_rhythm"><div>Surgical management for cleft lip/palate and other craniofacial anomalies; therapy for speech problems secondary to the cleft lip and palate</div></li><li class="half_rhythm"><div>Surgical repair as needed for heart defects</div></li><li class="half_rhythm"><div>Surgical intervention for imperforate anus</div></li><li class="half_rhythm"><div>Treatment as needed by an ophthalmologist</div></li></ul></div><div id="opitz.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Antireflux pharmacologic therapy minimizes the risk for aspiration until laryngeal competence is assured.</p></div><div id="opitz.Surveillance"><h3>Surveillance</h3><p>Regular follow up depending on the type of malformations present:</p><ul><li class="half_rhythm"><div>Urology follow up for those with significant hypospadias and/or renal defects</div></li><li class="half_rhythm"><div>Gastroenterology, pulmonary, and/or surgical follow up for those with LTE defects</div></li><li class="half_rhythm"><div>Craniofacial team follow up for those with cleft lip/palate, including regular monitoring of hearing</div></li><li class="half_rhythm"><div>Cardiac follow up for those with cardiac defects</div></li><li class="half_rhythm"><div>Gastroenterology and/or surgical follow up for those with anal defects</div></li></ul></div><div id="opitz.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#opitz.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="opitz.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="opitz.Genetic_Counseling"><h2 id="_opitz_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="opitz.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS) is inherited in an X-linked manner.</p></div><div id="opitz.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). Note: If a woman has more than one affected child and no other affected relatives and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis reveals that the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. <i>De novo</i> pathogenic variants have been detected in several affected males [<a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>, <a class="bk_pop" href="#opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the pathogenic variant will be carriers and will usually manifest hypertelorism only.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in DNA extracted from the leukocytes of the mother, the risk to sibs is low but slightly greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to:</p><ul><li class="half_rhythm"><div>All of their daughters, who will be heterozygotes (carriers) and will usually manifest hypertelorism only;</div></li><li class="half_rhythm"><div>None of their sons.</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes (carriers) for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and the aunt's offspring, depending on their gender, may be at risk of being heterozygotes (carriers) or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p>Note: Molecular genetic testing may be able to identify the family member in whom a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> arose, information that could help determine genetic risk status of the extended family.</p></div><div id="opitz.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: (1) Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (carriers) for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder will usually manifest hypertelorism only. (2) Identification of female heterozygotes requires either (a) prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and if no pathogenic variant is identified, by <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div><div id="opitz.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="opitz.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>MID1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for X-OS are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="opitz.Resources"><h2 id="_opitz_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Cleft Palate Foundation (CPF)</b></div><div>1504 East Franklin Street</div><div>Suite 102</div><div>Chapel Hill NC 27514-2820</div><div><b>Phone:</b> 800-242-5338 (toll-free); 919-933-9044</div><div><b>Fax:</b> 919-933-9604</div><div><b>Email:</b> info@cleftline.org</div><div><a href="http://www.cleftline.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cleftline.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/003000.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypospadias repair</a></div></li></ul></div><div id="opitz.Molecular_Genetics"><h2 id="_opitz_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="opitz.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>X-Linked Opitz G/BBB Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1327/table/opitz.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opitz.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_opitz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_opitz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_opitz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_opitz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_opitz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_opitz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_opitz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4281" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MID1</i></a></td><td headers="hd_b_opitz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4281" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp22<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_opitz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O15344" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">E3 ubiquitin-protein ligase Midline-1</a></td><td headers="hd_b_opitz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/MID1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MID1 @ LOVD</a></td><td headers="hd_b_opitz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MID1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MID1</a></td><td headers="hd_b_opitz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MID1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MID1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="opitz.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="opitz.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for X-Linked Opitz G/BBB Syndrome (<a href="/omim/300000,300552" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1327/table/opitz.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opitz.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">OPITZ GBBB SYNDROME, TYPE I; GBBB1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300552" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300552</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MIDLINE 1; MID1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>MID1</i> is composed of nine coding exons and variable and alternative 5' untranslated regions [<a class="bk_pop" href="#opitz.REF.quaderi.1997.285">Quaderi et al 1997</a>, <a class="bk_pop" href="#opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</a>, <a class="bk_pop" href="#opitz.REF.perry.1998.299">Perry et al 1998</a>, <a class="bk_pop" href="#opitz.REF.van_den_veyver.1998.251">Van den Veyver et al 1998</a>, <a class="bk_pop" href="#opitz.REF.cox.2000.2553">Cox et al 2000</a>, <a class="bk_pop" href="#opitz.REF.landry.2002.499">Landry &#x00026; Mager 2002</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1327/#opitz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, pathogenic variants in <i>MID1</i> have been found in approximately 85 individuals with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz G/BBB syndrome (X-OS) [<a class="bk_pop" href="#opitz.REF.gaudenz.1998.703">Gaudenz et al 1998</a>, <a class="bk_pop" href="#opitz.REF.cox.2000.2553">Cox et al 2000</a>, <a class="bk_pop" href="#opitz.REF.de_falco.2003.222">De Falco et al 2003</a>, <a class="bk_pop" href="#opitz.REF.winter.2003.249">Winter et al 2003</a>, <a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>, <a class="bk_pop" href="#opitz.REF.so.2005.1">So et al 2005</a>, <a class="bk_pop" href="#opitz.REF.mnayer.2006.198">Mnayer et al 2006</a>, <a class="bk_pop" href="#opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>, <a class="bk_pop" href="#opitz.REF.hu.2012.726">Hu et al 2012</a>, <a class="bk_pop" href="#opitz.REF.h_ning.2013.188">H&#x000fc;ning et al 2013</a>, <a class="bk_pop" href="#opitz.REF.migliore.2013.404">Migliore et al 2013</a>, <a class="bk_pop" href="#opitz.REF.ji.2014.140">Ji et al 2014</a>, <a class="bk_pop" href="#opitz.REF.li.2015.95">Li et al 2015</a>]. Several pathogenic variants predicted to result in arginine to stop changes, including p.Arg277Ter, p.Arg368Ter and p.Arg495Ter, are recurrent variants [<a class="bk_pop" href="#opitz.REF.cox.2000.2553">Cox et al 2000</a>, <a class="bk_pop" href="#opitz.REF.pinson.2004.381">Pinson et al 2004</a>, <a class="bk_pop" href="#opitz.REF.preiksaitiene.2015.7">Preiksaitiene et al 2015</a>]. The other pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, small deletions, or insertions located along the entire length of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> &#x02013; the majority in the most 3' portion of the gene.</p><p><i>MID1</i> whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions as well as single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions and duplications have been reported [<a class="bk_pop" href="#opitz.REF.winter.2003.249">Winter et al 2003</a>, <a class="bk_pop" href="#opitz.REF.ferrentino.2007.206">Ferrentino et al 2007</a>, <a class="bk_pop" href="#opitz.REF.fontanella.2008.584">Fontanella et al 2008</a>, <a class="bk_pop" href="#opitz.REF.h_ning.2013.188">H&#x000fc;ning et al 2013</a>, <a class="bk_pop" href="#opitz.REF.migliore.2013.404">Migliore et al 2013</a>].</p><div id="opitz.T.mid1_variants_discussed_in_this" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>MID1</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1327/table/opitz.T.mid1_variants_discussed_in_this/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opitz.T.mid1_variants_discussed_in_this_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.829C&#x0003e;T</td><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg227Ter</td><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000381.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000381<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_000372.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000372<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1102C&#x0003e;T</td><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg368Ter</td></tr><tr><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1483C&#x0003e;T</td><td headers="hd_h_opitz.T.mid1_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg495Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal gene product is E3 ubiquitin-protein ligase Midline-1, which is anchored to the microtubules [<a class="bk_pop" href="#opitz.REF.cainarca.1999.1387">Cainarca et al 1999</a>, <a class="bk_pop" href="#opitz.REF.schweiger.1999.2794">Schweiger et al 1999</a>, <a class="bk_pop" href="#opitz.REF.cox.2000.2553">Cox et al 2000</a>] and acts as an E3 ubiquitin ligase that regulates the degradation of phosphatase 2A [<a class="bk_pop" href="#opitz.REF.liu.2001.6650">Liu et al 2001</a>, <a class="bk_pop" href="#opitz.REF.trockenbacher.2001.287">Trockenbacher et al 2001</a>, <a class="bk_pop" href="#opitz.REF.short.2002.1">Short et al 2002</a>]. The role of this protein function within the cell and during development is yet to be clarified.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and truncated forms lower their affinity for the microtubular apparatus. The pathogenic mechanism is likely to be caused by the loss of E3 ubiquitin-protein ligase Midline-1 function on the microtubules.</p></div><div id="opitz.References"><h2 id="_opitz_References_">References</h2><div id="opitz.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.cainarca.1999.1387">Cainarca S, Messali S, Ballabio A, Meroni G. Functional characterization of the Opitz syndrome gene product (midin): evidence for homodimerization and association with microtubules throughout the cell cycle. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:1387–96.</span> [<a href="/pubmed/10400985" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10400985</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.cox.2000.2553">Cox TC, Allen LR, Cox LL, Hopwood B, Goodwin B, Haan E, Suthers GK. New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:2553–62.</span> [<a href="/pubmed/11030761" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11030761</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.de_falco.2003.222">De Falco F, Cainarca S, Andolfi G, Ferrentino R, Berti C, Rodriguez Criado G, Rittinger O, Dennis N, Odent S, Rastogi A, Liebelt J, Chitayat D, Winter R, Jawanda H, Ballabio A, Franco B, Meroni G. X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum. <span><span class="ref-journal">Am J Med Genet. </span>2003;<span class="ref-vol">120A</span>:222–8.</span> [<a href="/pubmed/12833403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12833403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.ferrentino.2007.206">Ferrentino R, Bassi MT, Chitayat D, Tabolacci E, Meroni G. MID1 mutation screening in a large cohort of Opitz G/BBB syndrome patients: twenty-nine novel mutations identified. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:206–7.</span> [<a href="/pubmed/17221865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17221865</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.fontanella.2008.584">Fontanella B, Russolillo G, Meroni G. MID1 mutations in patients with X-linked Opitz G/BBB syndrome. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:584–94.</span> [<a href="/pubmed/18360914" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18360914</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.gaudenz.1998.703">Gaudenz K, Roessler E, Quaderi N, Franco B, Feldman G, Gasser DL, Wittwer B, Horst J, Montini E, Opitz JM, Ballabio A, Muenke M. Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:703–10.</span> [<a href="/pmc/articles/PMC1377398/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377398</span></a>] [<a href="/pubmed/9718340" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9718340</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.hu.2012.726">Hu CH, Liu YF, Yu JS, Ng YY, Chen SJ, Su PH, Chen JY. A. MID1 gene mutation in a patient with Opitz G/BBB syndrome that altered the 3D structure of SPRY domain. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:726–31.</span> [<a href="/pubmed/22407675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22407675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.h_ning.2013.188">H&#x000fc;ning I, Kutsche K, Rajaei S, Erlandsson A, Lovmar L, Rundberg J, Stefanova M. Exon 2 duplication of the MID1 gene in a patient with a mild phenotype of Opitz G/BBB syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2013;<span class="ref-vol">56</span>:188–91.</span> [<a href="/pubmed/23354372" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23354372</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.ji.2014.140">Ji X, Xing Y, Xu Y, Liu Y, Chen Y, Tao J, Xiao B. A novel mutation in MID1 in a patient with X-linked Opitz G/BBB syndrome. <span><span class="ref-journal">Gene. </span>2014;<span class="ref-vol">537</span>:140–2.</span> [<a href="/pubmed/24374473" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24374473</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.landry.2002.499">Landry JR, Mager DL. Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1. <span><span class="ref-journal">Genomics. </span>2002;<span class="ref-vol">80</span>:499–508.</span> [<a href="/pubmed/12408967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12408967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.li.2015.95">Li B, Zhou T, Zou Y. Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. <span><span class="ref-journal">Mol Genet Genomic Med. </span>2015;<span class="ref-vol">4</span>:95–105.</span> [<a href="/pmc/articles/PMC4707030/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4707030</span></a>] [<a href="/pubmed/26788540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26788540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.liu.2001.6650">Liu J, Prickett TD, Elliott E, Meroni G, Brautigan DL. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:6650–5.</span> [<a href="/pmc/articles/PMC34408/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC34408</span></a>] [<a href="/pubmed/11371618" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11371618</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.migliore.2013.404">Migliore C, Athanasakis E, Dahoun S, Wonkam A, Lees M, Calabrese O, Connell F, Lynch SA, Izzi C, Pompilii E, Thakur S, van Maarle M, Wilson LC, Meroni G. Complex rearrangement of the exon 6 genomic region among Opitz G/BBB syndrome MID1 alterations. <span><span class="ref-journal">Eur J Med Genet. </span>2013;<span class="ref-vol">56</span>:404–10.</span> [<a href="/pubmed/23791568" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23791568</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.mnayer.2006.198">Mnayer L, Khuri S, Merheby HA, Meroni G, Elsas LJ. A structure-function study of MID1 mutations associated with a mild Opitz phenotype. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">87</span>:198–203.</span> [<a href="/pubmed/16378742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16378742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.opitz.a">Opitz JM, Fr&#x000ed;as JL, Gutenberger JE, Pellet JR (1969a) The G syndrome of multiple congenital anomalies. Birth defects: Original Article Series V:95-102.</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.opitz.b">Opitz JM, Summitt RL, Smith DW (1969b) The BBB syndrome familial telecanthus with associated congenital anomalies. Birth Defects: Original Article Series V:86-94.</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.perry.1998.299">Perry J, Feather S, Smith A, Palmer S, Ashworth A. The human FXY gene is located within Xp22.3: implications for evolution of the mammalian X chromosome. <span><span class="ref-journal">Hum Mol Genet. </span>1998;<span class="ref-vol">7</span>:299–305.</span> [<a href="/pubmed/9425238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.pinson.2004.381">Pinson L, Auge J, Audollent S, Mattei G, Etchevers H, Gigarel N, Razavi F, Lacombe D, Odent S, Le Merrer M, Amiel J, Munnich A, Meroni G, Lyonnet S, Vekemans M, Attie-Bitach T. Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:381–6.</span> [<a href="/pmc/articles/PMC1735763/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735763</span></a>] [<a href="/pubmed/15121778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15121778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.preiksaitiene.2015.7">Preiksaitiene E, Krasovskaja N, Utkus A, Kasnauskiene J, Me&#x00161;kien&#x00117; R, Paulauskiene I, Valevi&#x0010d;ien&#x00117; NR, Ku&#x0010d;inskas V. R368X mutation in MID1 among recurrent mutations in patients with X-linked Opitz G/BBB syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2015;<span class="ref-vol">24</span>:7–12.</span> [<a href="/pubmed/25304119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25304119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.quaderi.1997.285">Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W, Feldman GJ, Volta M, Andolfi G, Gilgenkrantz S, Marion RW, Hennekam RC, Opitz JM, Muenke M, Ropers HH, Ballabio A. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:285–91.</span> [<a href="/pubmed/9354791" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9354791</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.robin.1996.305">Robin NH, Opitz JM, Muenke M. Opitz G/BBB syndrome: clinical comparisons of families linked to Xp22 and 22q, and a review of the literature. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">62</span>:305–17.</span> [<a href="/pubmed/8882794" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8882794</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.ruiter.2010.195">Ruiter M, Kamsteeg EJ, Meroni G, de Vries BB. A MID1 mutation associated with reduced penetrance of X-linked Opitz G/BBB syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2010;<span class="ref-vol">19</span>:195–7.</span> [<a href="/pubmed/20671548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20671548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.schweiger.1999.2794">Schweiger S, Foerster J, Lehmann T, Suckow V, Muller YA, Walter G, Davies T, Porter H, van Bokhoven H, Lunt PW, Traub P, Ropers HH. The Opitz syndrome gene product, MID1, associates with microtubules. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1999;<span class="ref-vol">96</span>:2794–9.</span> [<a href="/pmc/articles/PMC15848/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC15848</span></a>] [<a href="/pubmed/10077590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10077590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.shaw.2006.185">Shaw A, Longman C, Irving M, Splitt M. Neonatal teeth in X-linked Opitz (G/BBB) syndrome. <span><span class="ref-journal">Clin Dysmorphol. </span>2006;<span class="ref-vol">15</span>:185–6.</span> [<a href="/pubmed/16760742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16760742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.short.2002.1">Short KM, Hopwood B, Yi Z, Cox TC. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, Alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders. <span><span class="ref-journal">BMC Cell Biol. </span>2002;<span class="ref-vol">3</span>:1.</span> [<a href="/pmc/articles/PMC64779/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC64779</span></a>] [<a href="/pubmed/11806752" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11806752</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.so.2005.1">So J, Suckow V, Kijas Z, Kalscheuer V, Moser B, Winter J, Baars M, Firth H, Lunt P, Hamel B, Meinecke P, Moraine C, Odent S, Schinzel A, van der Smagt JJ, Devriendt K, Albrecht B, Gillessen-Kaesbach G, van der Burgt I, Petrij F, Faivre L, McGaughran J, McKenzie F, Opitz JM, Cox T, Schweiger S. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">132A</span>:1–7.</span> [<a href="/pubmed/15558842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15558842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.trockenbacher.2001.287">Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, Schneider R, Schweiger S. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. <span><span class="ref-journal">Nat Genet. </span>2001;<span class="ref-vol">29</span>:287–94.</span> [<a href="/pubmed/11685209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11685209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.van_den_veyver.1998.251">Van den Veyver IB, Cormier TA, Jurecic V, Baldini A, Zoghbi HY. Characterization and physical mapping in human and mouse of a novel RING finger gene in Xp22. <span><span class="ref-journal">Genomics. </span>1998;<span class="ref-vol">51</span>:251–61.</span> [<a href="/pubmed/9722948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9722948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.winter.2003.249">Winter J, Lehmann T, Suckow V, Kijas Z, Kulozik A, Kalscheuer V, Hamel B, Devriendt K, Opitz J, Lenzner S, Ropers HH, Schweiger S. Duplication of the MID1 first exon in a patient with Opitz G/BBB syndrome. <span><span class="ref-journal">Hum Genet. </span>2003;<span class="ref-vol">112</span>:249–54.</span> [<a href="/pubmed/12545276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12545276</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opitz.REF.zhang.2011.348">Zhang X, Chen Y, Zhao S, Markljung E, Nordenskj&#x000f6;ld A. Hypospadias associated with hypertelorism, the mildest phenotype of Opitz syndrome. <span><span class="ref-journal">J Hum Genet. </span>2011;<span class="ref-vol">56</span>:348–51.</span> [<a href="/pubmed/21326312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21326312</span></a>]</div></li></ul></div></div><div id="opitz.Chapter_Notes"><h2 id="_opitz_Chapter_Notes_">Chapter Notes</h2><div id="opitz.Author_Notes"><h3>Author Notes</h3><p><b>Focus.</b> Basic research on the molecular basis of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> Opitz syndrome, functional study of <i>MID1</i> and proteins belonging to the TRIM/RBCC family</p></div><div id="opitz.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>5 April 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 July 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 June 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>18 January 2007 (me) Comprehensive update posted to live Web site</div></li><li class="half_rhythm"><div>17 December 2004 (me) Review posted to live Web site</div></li><li class="half_rhythm"><div>30 June 2004 (gm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1327</span><span class="label">PMID: <a href="/pubmed/20301502" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301502</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mtm/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/opd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1327&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1327/?report=reader">PubReader</a></li><li><a href="/books/NBK1327/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1327" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1327" style="display:none" title="Cite this Page"><div class="bk_tt">Meroni G. X-Linked Opitz G/BBB Syndrome. 2004 Dec 17 [Updated 2018 Apr 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1327/pdf/Bookshelf_NBK1327.pdf">PDF version of this page</a> (203K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#opitz.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#opitz.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#opitz.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#opitz.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#opitz.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#opitz.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#opitz.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#opitz.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#opitz.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#opitz.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#opitz.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4281[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MID1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1485744" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1485744" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1485744" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1485744" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301398" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Simpson-Golabi-Behmel Syndrome Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sajorda BJ, Gonzalez-Gandolfi CX, Hathaway ER, Kalish JM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301719" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MED12</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MED12</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lyons MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301567" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Otopalatodigital Spectrum Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Robertson S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301502" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301502" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041155dd21425a25a13ad2">X-Linked Opitz G/BBB Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">X-Linked Opitz G/BBB Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:48:05-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88C08DE03FA1510000000008F7033F&amp;ncbi_session=CE88C08DE0411551_2295SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1327%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1327&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1327/&amp;ncbi_pagename=X-Linked Opitz G/BBB Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88C08DE0411551_2295SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>